Adverum biotech Inc Live Stock Price Today, Share Analysis and Chart

Name: Adverum Biotechnologies Inc: Is Infosys Ltd. worth buying?
Item: Adverum Biotechnologies Inc
Rating: 1.42300
Author: Trendlyne DVM scores

about

Adverum Biotechnologies Inc is a clinical-stage company that aims to establish gene therapy as a new standard of care for prevalent ocular diseases. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustaine...

4.12 -0.04 (-0.96%)

40.97% Fall from 52W High

103.5K

XNAS Volume

XNAS 28 Nov, 2025 4:30 PM (EST)

Not Eligible

Expensive Valuation

0.0 / 100

Technically Neutral

56.9 / 100

1Yr Price target upside is 19%

5 analysts

Adverum biotech Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Adverum biotech Inc Live Stock Price Today, Share Analysis and Chart

Adverum Biotechnologies Inc is a clinical-stage company that aims to establish gene therapy as a new standard of care for prevalent ocular diseases. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustaine...

40.97% Fall from 52W High

SWOT Analysis

Adverum biotech Inc Live Price Chart